Biotech News
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
ir.macrogenics.com2026-05-11 21:27 EST
•MacroGenics to receive $122.5 million upfront payment from Bora upon closing •Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May 11, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical